Studies show in mice show that targeting the metabolic pathways could inhibit the growth of melanoma and combining this ...

Now, a new vaccine designed to train the body’s immune system to attack this rogue protein is showing promise in early trials ...

The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.

A mother and daughter from Newport News, both diagnosed with colon cancer, share their story, hoping it will encourage others ...

A new study led by investigators from Mass General Brigham trialed stereotactic (targeted) brain-directed radiation in 100 ...

Overall, 35% of patients' records had evidence of comprehensive genomic profiling (CGP). The rate increased modestly from 32% at the beginning of the study period to 39% at the end, reported Stacey ...

In order to produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic ...

I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive ...

Carter Wheeler, 7, is battling Stage 4 Neuroblastoma. Here's how to make his birthday on July 27 extra special while he's in ...

The FDA granted fast track designation to TRE-515 plus radioligand therapy for treating PSMA-positive metastatic ...

The Foundation Haiti Against Cancer in Infant (FHACI) is hosting a Summer Brunch on July 13th in Florida to raise essential ...

Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...